Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes

Molecular Medicine Reports

Volumn 9, Issue 5, 2014, Pages 1941-1946

  Yang, Zheng ^a,b   Liu, Yuan ^a,b   Deng, Wei ^a,b   Dai, Jia ^a,b   Li, Fangfang ^a,b   Yuan, Yuan ^a,b   Wu, Qingqing ^a,b   Zhou, Heng ^a,b   Bian, Zhouyan ^a,b   Tang, Qizhu ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cardiomyopathy; Hesperetin; Lipopolysaccharide; Mitochondria

Indexed keywords

CASPASE 3; CASPASE 9; HESPERETIN; LIPOPOLYSACCHARIDE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HEART MUSCLE; MITOCHONDRION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CELL LINE; CELL SURVIVAL; HESPERIDIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MITOCHONDRIA; MYOCYTES, CARDIAC; RATS; SIGNAL TRANSDUCTION;

EID: 84899563600     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2002     Document Type: Article

References (34)

1. Marcus FI, Edson S and Towbin JA: Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J Am Coll Cardiol 61: 1945-1948, 2013.
2. Sanbe A: Dilated cardiomyopathy: a disease of the myocardium. Biol Pharm Bull 36: 18-22, 2013.
3. Buerke U, Carter JM, Schlitt A, Russ M, Schmidt H, Sibelius U, Grandel U, Grimminger F, Seeger W, Mueller-Werdan U, Werdan K and Buerke M: Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock 29: 497-503, 2008.
4. Lu D, Ma Y, Zhang W, Bao D, Dong W, Lian H, Huang L and Zhang L: Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Hypertension 60: 81-89, 2012.
5. Westermann D, Savvatis K, Lindner D, Zietsch C, Becher PM, Hammer E, Heimesaat MM, Bereswill S, Völker U, Escher F, Riad A, Plendl J, Klingel K, Poller W, Schultheiss HP and Tschöpe C: Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy. Circulation 124: 2082-2093, 2011.
6. Consoli C, Gatta L, Iellamo F, Molinari F, Rosano GM and Marlier LN: Severity of left ventricular dysfunction in heart failure patients affects the degree of serum-induced cardiomyocyte apoptosis. Importance of inflammatory response and metabolism. Int J Cardiol 167: 2859-2866, 2013.
7. Loughran JH, Chugh AR, Ismail I and Bolli R: Stem cell therapy: promising treatment in heart failure? Curr Heart Fail Rep 10: 73-80, 2013.
8. Carneiro AV: Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a scientific review. I. Introduction. Rev Port Cardiol 27: 851-856, 2008 (In Portuguese).
9. Tang WH and Huang Y: Cardiotonic modulation in heart failure: insights from traditional Chinese medicine. J Am Coll Cardiol 62: 1073-1074, 2013.
10. Beadle R and Williams L: Device therapy in hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther 8: 1767-1775, 2010.
11. Del Corsso C and Campos de Carvalho AC: Cell therapy in dilated cardiomyopathy: from animal models to clinical trials. Braz J Med Biol Res 44: 388-393, 2011.
12. Wang J, Zhu H, Yang Z and Liu Z: Antioxidative effects of hesperetin against lead acetate-induced oxidative stress in rats. Indian. J Pharmacol 45: 395-398, 2013.
13. Deng W, Jiang D, Fang Y, Zhou H, Cheng Z, Lin Y, Zhang R, Zhang J, Pu P, Liu Y, Bian Z and Tang Q: Hesperetin protects against cardiac remodelling induced by pressure overload in mice. J Mol Histol 44: 575-585, 2013.
14. Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S and Saxena R: Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats. Vascul Pharmacol 57: 201-107, 2012.
15. Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S, Saxena R and Jha KA: Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc Res 87: 65-74, 2013.
16. Sambantham S, Radha M, Paramasivam A, Anandan B, Malathi R, Chandra SR and Jayaraman G: Molecular mechanism underlying hesperetin-induced apoptosis by in silico analysis and in prostate cancer PC-3 cells. Asian Pac J Cancer Prev 14: 4347-4352, 2013.
17. Morikawa K, Nonaka M, Mochizuki H, Handa K, Hanada H and Hirota K: Naringenin and hesperetin induce growth arrest, apoptosis, and cytoplasmic fat deposit in human preadipocytes. J Agric Food Chem 56: 11030-11037, 2008.
18. Yang S, Li R, Qu X, Tang L, Ge G, Fang W, Qiao Z, Ma J, Hou Y and Liu H: Fosinoprilat alleviates lipopolysaccharide (LPS)-induced inflammation by inhibiting TLR4/NF-κB signaling in monocytes. Cell Immunol 284: 182-186, 2013.
19. Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY and Du SX: Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Cell Physiol Biochem 30: 123-136, 2012.
20. Niu L, Qiao W, Li G, Li Q, Huang Q, Gong J, Zhu W, Li N and Li J: Different alterations in rat intestinal glutamine transport during the progression of CLP- and LPS-induced sepsis. J Surg Res 169: 284-291, 2011.
21. Lei L, Wang J, Zhang Z, Zhang H, Chen H and Cai D: Lipopolysaccharide- induced apoptosis in a murine intestinal endocrine cell line by modulation of Bcl-2, Bax and caspase-3. Mol Med Rep 8: 1649-1654, 2013.
22. Sears SF, Woodrow L, Cutitta K, Ford J, Shea JB and Cahill J: A patient's guide to living confidently with chronic heart failure. Circulation 127: e525-e528, 2013.
23. Paraskevaidis I, Palios J, Parissis J, Filippatos G and Anastasiou-Nana M: Treating depression in coronary artery disease and chronic heart failure: what's new in using selective serotonin re-uptake inhibitors? Cardiovasc Hematol Agents Med Chem 10: 109-115, 2012.
24. Fujita T and Ishikawa Y: Apoptosis in heart failure. -The role of the β-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes-. Circ J 75: 1811-1818, 2011.
25. Peng Z, Wang H, Zhang R, Chen Y, Xue F, Nie H, Chen Y, Wu D, Wang Y, Wang H and Tan Q: Gastrodin ameliorates anxiety-like behaviors and inhibits IL-1beta level and p38 MAPK phosphorylation of hippocampus in the rat model of posttraumatic stress disorder. Physiol Res 62: 537-545, 2013.
26. Yuk TH, Kang JH, Lee SR, Yuk SW, Lee KG, Song BY, Kim CH, Kim DW, Dong IK, Lee TK and Lee CH: Inhibitory effect of Carthamus tinctorius L. seed extracts on bone resorption mediated by tyrosine kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E2. Am J Chin Med 30: 95-108, 2002.
27. Choi EM and Lee YS: Effects of hesperetin on the production of inflammatory mediators in IL-1beta treated human synovial cells. Cell Immunol 264: 1-3, 2010.
28. Dong M, Hu N, Hua Y, Xu X, Kandadi MR, Guo R, Jiang S, Nair S, Hu D and Ren J: Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress. Biochim Biophys Acta 1832: 848-863, 2013.
29. Wang XL, Wang X, Xiong LL, Zhu Y, Chen HL, Chen JX, Wang XX, Li RL, Guo ZY, Li P and Jiang W: Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis: doxorubicin cardiotoxicity inhibited by salidroside. J Cardiovasc Pharmacol 62: 512-523, 2013.
30. Mairuae N, Hall Ii EC, Cheepsunthorn P, Lee SY and Connor JR: The H63D HFE gene variant promotes activation of the intrinsic apoptotic pathway via mitochondria dysfunction following β-amyloid peptide exposure. J Neurosci Res 88: 3079-3089, 2010.
31. Chai WS, Zhu XM, Li SH, Fan JX and Chen BY: Role of Bcl-2 family members in caspase-3/9-dependent apoptosis during Pseudomonas aeruginosa infection in U937 cells. Apoptosis 13: 833-843, 2008.
32. Chen M, Guerrero AD, Huang L, Shabier Z, Pan M, Tan TH and Wang J: Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem 282: 33888-33895, 2007.
33. Barrezueta LF, Oshima CT, Lima FO, De Oliveira Costa H, Gomes TS, Neto RA and De Franco MF: The intrinsic apoptotic signaling pathway in gastric adenocarcinomas of Brazilian patients: Immunoexpression of the Bcl-2 family (Bcl-2, Bcl-x, Bak, Bax, Bad) determined by tissue microarray analysis. Mol Med Rep 3: 261-267, 2010.
34. Zhai CL, Zhang MQ, Zhang Y, Xu HX, Wang JM, An GP, Wang YY and Li L: Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway. Acta Pharmacol Sin 33: 1477-1487, 2012.